Interferoning with natural history: dollars and sense.
R L
RL
Koretz
J
J
Ofman
D002908:Chronic Disease; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006509:Hepatitis B / Q000276:immunology* / Q000628:therapy*; D006511:Hepatitis B Antigens / Q000032:analysis*; D006801:Humans; D016898:Interferon-alpha / Q000191:economics* / Q000627:therapeutic use*
D006511:Hepatitis B Antigens; D016898:Interferon-alpha